Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)
25th January 2022
Portfolio
This post references, or is about Imara. Find out more by clicking below